Recent Funding Corvus Pharmaceuticals secured $30.6 million in funding recently, indicating financial stability and potential for new product development or market expansion.
Key Hires Recent appointments of Jeffrey Arcara as Chief Business Officer and James Rosenbaum as Senior Vice President of Research demonstrate expansion plans and potential collaborations, offering avenues for partnership and sales growth.
Product Development Updates Corvus Pharmaceuticals regularly updates on their development programs like CPI-818 and mupadolimab, showcasing innovative and promising products that could attract interest from potential investors or collaborators.
Market Presence As a publicly traded company, the market presence of Corvus Pharmaceuticals is increasing, providing opportunities for sales growth through heightened visibility and potential investor interest.
Technology Stack By utilizing a tech stack including Google Analytics, Vue.js, and Zoom, Corvus Pharmaceuticals shows a commitment to innovative solutions, which can attract tech-savvy clients and partners seeking cutting-edge biotech companies to collaborate with.
Corvus Pharmaceuticals uses 8 technology products and services including Google Analytics, Microsoft PowerPoint, Backbone.js, and more. Explore Corvus Pharmaceuticals's tech stack below.
| Corvus Pharmaceuticals Email Formats | Percentage |
| FLast@corvuspharma.com | 92% |
| Last@corvuspharma.com | 5% |
| Last_First@corvuspharma.com | 2% |
| FMLast@corvuspharma.com | 1% |
Biotechnology ResearchCalifornia, United States51-200 Employees
Corvus is a unique environment for exceptional individuals who want to learn, contribute to an exceptional team, and make a difference in the lives of people with cancer. At Corvus, we take pride in our collaborative, community-based culture. We understand that the most successful teams are those that learn from each other and co-create in an environment that nurtures open, transparent communication.
Company Overview
Media & News
Funding & FinancialsCorvus Pharmaceuticals has raised a total of $31M of funding over 6 rounds. Their latest funding round was raised on May 02, 2024 in the amount of $31M.
Corvus Pharmaceuticals's revenue is in the range of $10M$50M
Funding & FinancialsCorvus Pharmaceuticals has raised a total of $31M of funding over 6 rounds. Their latest funding round was raised on May 02, 2024 in the amount of $31M.
Corvus Pharmaceuticals's revenue is in the range of $10M$50M
Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.
1-888-653-2347 
support@leadiq.com